Prostate cancer (PRC) is the major reason of mortality globally. Early recognition and classification of PRC become essential to enhance the quality of healthcare services. A newly established deep learning (DL) and machine learning (ML) approach with different optimization tools can be employed to classify accurately of PRC accurately using microarray gene expression data (GED). Though the microarray data structures are important to diagnosing different kinds of diseases, the optimum hyperparameter tuning of the DL models poses a major challenge to achieving maximum classification performance. To resolve these issues, this study develops a new Gene Expression Data Analysis using Artificial Intelligence for Prostate Cancer Diagnoses (GEDAAI-PCD) technique. The proposed GEDAAI-PCD technique examines the GED for the identification of PRC. To accomplish this, the GEDAAI-PCD technique initially normalizes the GED into a uniform format. In addition, the long short-term memory-deep belief network (LSTM-DBN) model was applied for PRC classification purposes. The wild horse optimization (EWHO) system was utilized as a hyperparameter tuning strategy to optimize the performance of the LSTM-DBN model. The experimental assessment of the GEDAAI-PCD system occurs on open open-accessed gene expression database. The experimental outcomes emphasized the supremacy of the GEDAAI-PCD method on PRC classification.
This research paper delves into the realm of automated interview evaluation, employing state-of-the-art natural language processing models. The primary focus lies in comparing the effectiveness of TF-IDF, BERT, RoBERTa, Jaccard similarity, and Word2Vec models in assessing interview responses. The paper commences by providing a comprehensive definition of automated interview evaluation, highlighting the significance of efficient and unbiased candidate assessment. The proposed methodology involves the utilization of RoBERTa, a robust transformer-based model, to analyze and score interview responses. Through meticulous experimentation and evaluation, the research scrutinizes the performance of each model, examining its ability to capture contextual nuances and semantic understanding. The final results reveal the superior efficacy of RoBERTa over the other models, demonstrating its proficiency in evaluating interview responses and emphasizing its potential for enhancing automated hiring processes. This study contributes valuable insights into the evolving field of natural language processing and automated recruitment systems.
This research endeavors by combining transfer learning techniques with Convolutional Neural Networks (CNNs), this study aims to improve the categorization of breast cancer. The primary objective is to improve diagnostic precision in detecting malignancies from mammographic images, ultimately impacting clinical decision-making and patient care positively. The study employs a robust methodology utilizing a diverse dataset for training and validation. Transfer learning optimizes CNNs' efficiency, fine-tuning the architecture to adapt to breast cancer detection nuances. Rigorous training-validation cycles refine the model, ensuring generalizability across diverse datasets. The automated system minimizes subjective variability, contributing to a more objective diagnostic process. Scalability is achieved by designing the model to handle large volumes of mammographic images, a critical feature for widespread implementation. The integration of CNNs and transfer learning yields promising results, demonstrating a substantial improvement in accuracy compared to existing methods. Automation significantly reduces diagnosis time, while introduced objectivity minimizes result variability. The property of scalability shows promise for broad use since it works well in managing massive amounts of images. These outcomes highlight the viability and effectiveness of the suggested strategy in improving the diagnosis of breast cancer. In conclusion, the developed model, combining CNNs and transfer learning, represents a significant advancement with the potential to revolutionize clinical decision-making and patient care, offering a more accurate, efficient, and widely applicable approach to breast cancer diagnosis.